National Centre for Clinical Research on Emerging Drugs (NCCRED)
Clinical practice meets clinical research
Clinical practice meets clinical research
The National Centre for Clinical Research on Emerging Drugs (NCCRED) brings researchers, practitioners and consumers together to create a robust evidence base for treatment and interventions for people who use methamphetamine and emerging other drugs of concern.
NCCRED applies its vision by:
Through clinical research, NCCRED develops trials of pharmacotherapies and other clinical interventions for people who use methamphetamine and other emerging drugs of concern. Our activity in this stream includes:
NCCRED also develops trials of digital interventions to promote treatment-seeking and behaviour change among people with methamphetamine use disorder. This includes an internet-based cognitive behavioural therapy intervention and the S-Check app.
The rapid emergence of novel psychoactive substances is a key public health challenge in Australia. The distributed nature of this challenge makes the sharing of information across jurisdictions and sectors highly important.
NCCRED facilitates effective national information sharing needed to evaluate and respond to emerging drug harms, through the Prompt Response Network. This includes:
People working in the AOD sector need access to reliable and timely information about emerging drugs of concern in order to deliver effective care. NCCRED communicates research outcomes and information about emerging drugs of concern.
Our activity in this stream includes:
Professor Nadine Ezard
Director, National Centre for Clinical Research on Emerging Drugs | Clinical Director, Alcohol and Drug Service St Vincent's Hospital Sydney Australia
E: n.ezard@unsw.edu.au
Jemma Hallen
Project Manager, National Centre for Clinical Research on Emerging Drugs